Christopher Gagliardi: Ledger

Stories naming Christopher Gagliardi. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Director	AdvanCell	Startup Daily, Brandon Capital

Series C US$112m

AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing

Sydney cancer-therapy developer AdvanCell has completed a US$112 million Series C that was oversubscribed, co-led by four investors, with Brandon Capital among new backers; three investor representatives join the board.

Brandon Capital portfolio 3 Feb 2025 AdvanCell Abingworth Brandon Capital Morningside Sanofi Ventures SV Health Investors SymBiosis Tenmile Andrew Adamovich Bali Muralidhar Bill Ferris AC Christopher Gagliardi Jamil M. Beg

Also Startup Daily·SmartCompany·Forbes Australia

Christopher Gagliardi

Roles

Coverage

Cancer treatment biotech AdvanCell injects $178 million Series C

AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing